Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Taking PBMs To The “OR”: Orphan Reinsurance Model Could Be New “Middleman” Role
Mar 24 2019
•
By
Michael McCaughan
A proposal for orphan product reinsurance could create a new theater where drug "middlemen" could operate.
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Rare Diseases
More from Pink Sheet